Thermo Fisher Scientific (TMO) Stock Gets Fair Value Bump After Q2 Driven Analyst Target Increases

Thermo Fisher Scientific’s fair value estimate has shifted from US$652.85 to US$686.64, pointing to a modestly higher price target in current models. Recent analyst commentary ties this change to more supportive views on Q2 results, sector demand trends and updated company guidance, even as opinions remain split between bullish and more cautious takes. As you read on, you will see how this evolving narrative fits together and what to watch next as new research comes out. Analyst Price Targets...